Medicine & Life Sciences
Angiotensin II
100%
Regulatory T-Lymphocytes
76%
CD40 Ligand
64%
Salts
63%
Isoantigens
63%
Diet
61%
Sirolimus
54%
Blood Vessels
49%
Transplants
48%
B-Lymphocytes
39%
Iloprost
33%
Superoxides
31%
Demethylation
30%
Middle Cerebral Artery
28%
Sodium-Restricted Diet
28%
Antigen-Presenting Cells
27%
Aorta
26%
Oxidants
26%
Cricetinae
26%
Cheek
25%
ErbB Receptors
24%
Cell- and Tissue-Based Therapy
24%
Transcriptional Activation
23%
Immunosuppression
23%
Nitric Oxide
23%
Methacholine Chloride
23%
Interleukin-2
23%
Transplantation
19%
Dilatation
17%
RTKI cpd
15%
KATP Channels
13%
Intravenous Infusions
12%
Acetylcholine
12%
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
12%
Endothelium
12%
Cycloheximide
11%
Peptidyl-Dipeptidase A
11%
Immunosuppressive Agents
10%
Vasodilator Agents
10%
Epidermal Growth Factor
10%
Constriction
9%
Sprague Dawley Rats
9%
tempol
9%
carboprostacyclin
9%
Transplantation Tolerance
8%
Self Tolerance
8%
Clinical Trials, Phase I
7%
Immune Tolerance
7%
Cromakalim
7%
Chemical Compounds
Immunosuppressive Agent
34%
Angiotensin II
32%
Angiotensin
24%
Nephrotoxic
19%
Enzyme Inhibition
15%
Iloprost
11%
Cromakalim
11%
Toxic
9%
Sodium Nitroprusside
9%
Captopril
8%
Acetylcholine
6%